Protective roles of adenosine A1, A2A, and A 3 receptors in skeletal muscle ischemia and reperfusion injury

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 6, 2007, Pages

  Zheng, Jingang ^a   Wang, Rubio ^a   Zambraski, Edward ^b   Wu, Dan ^a   Jacobson, Kenneth A ^c   Liang, Bruce T ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b U S ARMY RESEARCH INSTITUTE OF ENVIRONMENTAL MEDICINE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Creatine kinase; Phosolipase C; Wild type mice

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 CHLORO N6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR BLOCKING AGENT; CREATINE KINASE; PHOSPHOLIPASE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME BLOOD LEVEL; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MUSCLE INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADENOSINE; ANIMALS; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; HINDLIMB; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; PHENETHYLAMINES; PHOSPHOLIPASE C BETA; PYRAZOLES; PYRIMIDINES; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; REPERFUSION INJURY; SIGNAL TRANSDUCTION; XANTHINES;

EID: 36849005071     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00819.2007     Document Type: Article

References (43)

1. Abonia JP, Friend DS, Austen WG Jr, Moore FD Jr, Carroll MC, Chan R, Afnan J, Humbles A, Gerard C, Knight P, Kanaoka Y, Yasuda S, Morokawa N, Austen KF, Stevens RL, Gurish MF. Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. J Immunol 174: 7285-7291, 2005.
2. 3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol 285: H607-H613, 2003.
3. 3 adenosine receptors reduces mouse intraocular pressure. Invest Ophthalmol Vis Sci 43: 3021-3026, 2002.
4. Beyersdorf F, Unger A, Wildhirt A, Kretzer U, Deutschlander N, Kruger S, Matheis G, Hanselmann A, Zimmer G, Satter P. Studies of reperfusion injury in skeletal muscle: preserved cellular viability after extended periods of warm ischemia. J Card Surg 32: 664-676, 1991.
5. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and perfusion syndrome: a review. Cardiovasc Surg 10: 620-630, 2002.
6. Bortolotto SK, Morrison WA, Han XL, Messina A. Mast cells play a pivotal role in ischemia reperfusion injury to skeletal muscle. Lab Invest 84: 1-9, 2004.
7. Bushell AJ, Klenerman L, Taylor S, Davies H, Grierson I, Helliwell TR, Jackson MJ. Ischaemic preconditioning of skeletal muscle. 1. Protection against the structural changes induced by ischemic/reperfusion injury. J Bone Joint Surg. 84: 1184-1188, 2002.
8. Bushell AJ, Klenerman L, Davies H, Grierson I, McArdle A, Jackson MJ. Ischaemic preconditioning of skeletal muscle. 2. Investigation of the potential mechanisms involved. J Bone Joint Surg. 84: 1189-1193, 2002.
9. Carrol CMA, Carrole SM, Overgoor MLE, Tobin G, Barker JH. Acute ischemic preconditioning of skeletal muscle prior to flap elevation augments muscle-flap survival. Plast Reconstr Surg 100: 58-65, 1997.
10. 3 adenosine receptors improves tolerance to ischemia-reperfusion injury in mouse myocardium. Am J Physiol Heart Circ Physiol 281: H1751-H1758, 2001.
11. Chan RK, Verna N, Afnan J, Zhang M, Ibrahim S, Carroll MC, Moore FD Jr. Attenuation of skeletal muscle reperfusion injury with intravenous 12 amino acid peptides that bind to pathogenic IgM. Surgery 139: 236-243, 2006.
12. + T cells and IFN-g. J Immunol 176: 3108-3114, 2006.
13. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen Holt J, KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R, Campbell KP. Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J Cell Biol 142: 1461-1471, 1998.
14. Durbeej M, Sawatzki SM, Barresi R, Schmainda KM, Allamand V, Michele DE, Campbell KP. Gene transfer establishes primacy of striated vs. smotth muscle sarcoglycan complex in limb-girdle muscular dystrophy. Proc Natl Acad Sci USA 100: 8910-8915, 2003.
15. Ecker P, Schnackerz K. Ischemic tolerance of human skeletal muscle. Ann Plast Surg 26: 77-84, 1991.
16. Fielding RA, Manfredi TJ, Ding W, Fiatarone MA, Evans WJ, Cannon JG. Acute phase response in exercise. III. Neutrophil and IL-1β accumulation in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 265: R166-R172, 1993.
17. Formigli L, Lombardo LD, Adembri C, Brunelleschi S, Ferrari E, Novelli GP. Neutrophils and mediators of human skeletal muscle ischemia-reperfusion syndrome. Hum Pathol 23: 627-634, 1992.
18. Gallin JI, Snyderman R. Inflammation: Basic Principles and Clinical Correlations, edited by Gallin JL, Snyderman R, Fearon DT, Haynes BF, and Nathan C. Philadelphia, PA: Lippincott Willliams & Wilkins, 1999, p. 1047-1061.
19. 3 adenosine receptor. J Pharmacol Exp Ther 319: 1200-1210, 2006.
20. 3 adenosine receptor activation and gene knockout in ischemic-reperfused mouse heart. Cardiovasc Res 53: 147-155, 2002.
21. Jiang H, Kuang Y, Wu Y, Smrcka A, Simon MI, Wu D. Pertussis toxin-sensitive activation of phospholipase C by the C5a and fMet-Leu-Phe receptors. J Biol Chem 271: 13430-13434, 1996.
22. 2b-dependent signaling during early reperfusion. J Mol Cell Cardiol 43: 262-271, 2007.
23. 2b receptor antagonist ZM-241385 blocks the cardioprotective effect of adenosine agonist pretreatment in in vivo rat myocardium. Am J Physiol Heart Circ Physiol 292: H426-H431, 2007.
24. 3 receptor: sustained cardioprotection. Proc Natl Acad Sci USA 95: 6995-6999, 1998.
25. 2A adenosine receptor in vivo. J Immunol 173: 21-24, 2004.
26. 3 receptor activation protects the myocardium from reperfusion/reoxygenation injury. Am J Physiol Heart Circ Physiol 283: H1307-H1313, 2002.
27. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
28. Pang CY, Neligan P, Zhong A, He W, Xu H, Forrest CR. Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction. Am J Physiol Regul Integr Comp Physiol 273: R887-R895, 1997.
29. Parsons M, Young L, Lee JE, Jacobson KA, Liang BT. Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB J 14: 1423-1431, 2000.
30. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268: 16887-16890, 1993.
31. Shen JB, Cronin C, Sonin D, Joshi BV, Nieto MG, Harrison D, Jacobson KA, Liang BT. P2X purinergic receptor-mediated ionic current in cardiac myocytes of calsequestrin model of cardiomyopathy: implications for the treatment of heart failure. Am J Physiol Heart Circ Physiol 292: H1077-H1084, 2007.
32. 2A receptors. Annu Rev Immunol 22: 657-682, 2004.
33. Sitkovsky M, Lukashev D. Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors. Nat Rev Immunol 5: 712-721, 2005.
34. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 46: 235-247, 1995.
35. Souza DG, Cara DC, Cassali GD, Coutinho SF, Silveira MR, Andrade SP, Poole SP, Teixeira MM. Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischemia of the superior mesenteric artery in the rat. Br J Pharmacol 131: 1800-1808, 2000.
36. 3 receptors augments adenosine-induced coronary flow in isolated mouse heart. Am J Physiol Heart Circ Physiol 282: H2183-H2189, 2002.
37. 3 receptors on mast cells. J Clin Invest 105: 361-367, 2000.
38. Tsuchida T, Kato T, Yamaga M, Ikebe K, Oniki Y, Irie H, Takagi K. The effect of perfusion with UW solution on the skeletal muscle and vascular endothelial exocrine function in rat hindlimbs. J Surg Res 110: 266-271, 2003.
39. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83: 1113-1151, 2003.
40. ATP channels. Am J Physiol Heart Circ Physiol 280: H1278-H1285, 2001.
41. 3 receptor in heart: role of NF-kB, iNOS and mitochondrial KATP channel. J Mol Cell Cardiol 34: 263-277, 2002.
42. 1 receptor-induced delayed cardioprotection in mouse. Am J Physiol Heart Circ Physiol 285: H434-H441, 2003.
43. 3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. Biochim Biophys Acta 1500: 280-290, 2000.